Reuters logo
BRIEF-Xenon Pharma announces initiation of XEN1101 phase 1 clinical trial
October 17, 2017 / 12:53 PM / a month ago

BRIEF-Xenon Pharma announces initiation of XEN1101 phase 1 clinical trial

Oct 17 (Reuters) - Xenon Pharmaceuticals Inc

* Xenon Pharmaceuticals announces initiation of XEN1101 phase 1 clinical trial

* XEN1101 phase 2 proof-of-concept clinical trial anticipated to begin in Q3 2018​

* Expect to file an IND equivalent application in Q4 of this year for XEN901​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below